Inflammatory Bowel Disease (IBD)
- A group of chronic intestinal diseases characterized by inflammation of
the bowel -- the large or small intestine.
- The most common types of inflammatory bowel disease are ulcerative
colitis and Crohn's disease.
- Ulcerative colitis and Crohn's disease have no medical cure. Once the diseases
begin, they tend to fluctuate between periods of inactivity (remission) and
activity (relapse).
- They affect approximately 500,000 to 2 million people in the United States.
- Men and women are equally affected.
- IBD most commonly begins during adolescence and early adulthood, but it
also can begin during childhood and later in life.
Crohn disease favors the ileum (the lower part of the small intestine)
but can occur anywhere along the intestinal tract while, by contrast, ulcerative
colitis affects the colon (the large intestine) alone. The inflammation in Crohn
disease involves the entire thickness of the bowel wall, whereas in ulcerative
colitis the inflammation is confined to the mucosa (the inner lining) of
the intestine.
Symptoms
- abdominal pain and diarrhea. The course is typically unpredictable.
- Symptoms tend to wax and wane, and long remissions and even the spontaneous
resolution of symptoms are well known.
- The disease can be limited to the intestine or affect the skin, joints,
spine, liver, eyes, and other organs. Although people of any age can have
inflammatory bowel disease, the diagnosis is most commonly first made in young
adults.
- Intestinal ulcers and bleeding are common in both Crohn disease and ulcerative
colitis. But complications such as intestinal strictures (narrowings), fistulas,
and fissures (tears) are far more common in Crohn disease than in ulcerative
colitis.
Small intestinal bacterial overgrowth in Crohn disease can result from an intestinal
stricture and is treated with antibiotics. Crohn disease of the duodenum and
jejunum can cause malabsorption of nutrients can cause malnutrition, weight
loss, and diarrhea. In Crohn disease of the ileum, malabsorption of bile salts
can cause diarrhea and malabsorption of vitamin B12 can lead to anemia.
There is an increased risk of colon cancer in ulcerative colitis. Yearly monitoring
with colonoscopies and biopsies of the colon for premalignant cells and cancer
is recommended for patients after 8 to 10 years of chronic inflammation of the
colon.
Treatment
- involves the use of medicines and sometimes surgery, depending upon the
type and course of the inflammatory bowel disease. Effective therapy exists
for the majority of cases. Narcotics, codeine, and anti-diarrheal medications
such as Lomotil and Imodium should be avoided during severe episodes of colitis
because they may induce a toxic megacolon.